The JSE closed weaker on Tuesday, with its global peers mixed as investors mull further restrictions amid rising Covid-19 cases in the US and Europe. 

Monday’s news that American biotechnology group Moderna’s Covid-19 vaccine is 94.5% effective was a welcome development. But with the vaccine deployment still some time away, efforts by authorities remain focused on slowing the spread as Europe and the US grapple with rising case numbers...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.